Asthma is a complex disease, whose principal characteristics include reversible airflow obstruction, airway hyperresponsiveness, airway inflammation, mucus hypersecretion and airway remodeling. This disease has reached epidemic proportions worldwide and typically starts early on in life. Asthma can be both chronic and heterogeneous and is often associated with allergies to airborne antigens.
Assessing airway responsiveness in response to aerosol challenges is the most frequently reported outcome for asthma research. When equipped with an integrated nebulizer, the flexiVent can be used to both deliver aerosol challenges to a subject’s lungs and follow the developing bronchoconstriction through automated data collection. Using proprietary algorithms, the system can calculate and display an estimate of the dose delivered to the subject’s airway opening. Detailed dose-response curves demonstrating airway hyperresponsiveness are computed and graphed in real-time.
Partitioning the response to describe the contribution from the central airways and tissue mechanics offers additional insight into disease severity and progression. It allows researchers to study pathophysiological mechanisms related to airway hyperresponsiveness in mice. Learn how a leading preclinical asthma researcher uses the flexiVent for their research in this interview!
Disease models are often generated by exposing subjects to aerosols of allergens using acute or chronic protocols in order to establish relevant asthma phenotypes. The inExpose has been specifically designed to allow for repetitive precise dosage delivery by controlling air flow rates and aerosol generation devices. This is done through automated exposure profiles, which also help to reduce user error and minimize outcome variations among subjects, studies, and research groups. The inExpose operates under various configurations and protocols to ensure that the subjects receive repeated yet consistent exposure environments throughout and between experimentation sessions.
In respiratory research, the most specific and precise measurements come at the cost of increased invasiveness. This has been described as the phenotyping uncertainty principle (PUP). For example, while the forced oscillation technique employed by the flexiVent system scores the highest in terms of measurement, accuracy, and precision, it lies the furthest from the subject’s natural state on an invasiveness continuum. On the other hand, as subjects are closer and closer to their natural state when using various plethysmography techniques, measurement specificity and precision register lower and lower on an accuracy continuum.
Various plethysmography techniques exist to measure lung function in preclinical studies: unrestrained whole body plethysmography (WBP), double chamber plethysmography (DCP), or head-out plethysmography (HOP). While each lung function measurement technique has value, the choice of the technique to be used should be weighed against the research objective and be based on a clear understanding of the technique, the outcomes, and the related liabilities. Measurements using plethysmography systems are done in conscious subjects where various external factors significantly impact the outcomes obtained.
The airway smooth muscle plays an undeniable role in asthma. The excessive amount of contraction it can generate as well as the enhanced sensitivity have been associated with key characteristics of asthma, namely bronchoconstriction and airway hyperresponsiveness. Studying its intrinsic ability to contact or relax in an isolated tissue bath where external influences can be removed can offer complimentary data to in vivo lung function measurements. This technique is a classic pharmacological tool that can be applied to various types of contractile tissues from different species.
Dr. Venkatachalem’s lab focuses on lung diseases such as asthma, chronic obstructive pulmonary disease, LAM, & pulmonary hypertension. This group is leading the research on elucidating the role of sex steroids in lung diseases like asthma.
Still researching your asthma animal model? Learn more about which animal is the most popular asthma animal model, the advantages and disadvantages of each, what goes into a successful model, the sensitization and challenge phases, and much more.
The Halayko lab focuses on the
pathogenesis of bronchial asthma and is at the forefront of preclinical asthma research. We sat down with Dr. Halayko to learn more about his work and get his thoughts on the current state and future of asthma research.
Save time evaluating SCIREQ equipment by having a SCIREQ Application Specialist conduct a custom
literature research. Researchers will receive an email report showing SCIREQ publications relevant to their specific application research area, along with custom equipment recommendations and commentary.